Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06916741 · ClinicalTrials.gov registry record · NA
Effect of a Sacral Lift on Femoral Vein Size and Exposure
A NA study of Femoral Artery and Cannulation, sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute).
- Recruiting
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT06916741: Recruiting NA study of Femoral Artery and Cannulation, sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute).
NCT06916741 is a NA study of Femoral Artery and Cannulation that is actively recruiting participants, run by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute). The registered enrollment target is 35 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06916741, a NA study of Femoral Artery and Cannulation, is actively recruiting participants, sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute).
- RECRUITING
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn if a sacral lift can improve femoral vein size and exposure, which may be clinically helpful during femoral vein cannulation among emergency department patients. The main questions it aims to answer are: Does a sacral lift increase femoral vein size compared to no sacral lift in both straight and frog-leg positions? Does a sacral lift improve femoral vein exposure (reduce overlap by the femoral artery) compared to no sacral lift in both straight and frog-leg positions? Researchers will compare femoral vein size and exposure measurements with and without a sacral lift in both straight and frog-leg leg positions to see if the sacral lift improves vein size and reduces artery overlap. Participants will: Undergo femoral vein ultrasound scans. Maintain a straight leg position with and without a sacral lift. Maintain a frog-leg position with and without a sacral lift.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Ultrasound with Sacral lift
Study Locations (1)
Pennsylvania
- Saint Vincent Hospital - Erie
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2025-07-23 |
| Est. Completion | 2027-12 |
| Phase | NA |
Sponsor
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)34 total trials
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06916741
The ClinicalTrials.gov registry entry for NCT06916741 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute), which has 34 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Femoral Artery appearing as the primary indexed condition, and to 1 intervention - of which Ultrasound with Sacral lift is the first listed.
NCT06916741 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06916741 about?
NCT06916741 is a clinical study titled "Effect of a Sacral Lift on Femoral Vein Size and Exposure". The goal of this clinical trial is to learn if a sacral lift can improve femoral vein size and exposure, which may be clinically helpful during femoral vein cannulation among emergency department patients. The main questions it aims to answer are: Does a sacral lift increase femoral vein size compa...
What is the current status of trial NCT06916741?
This trial is currently recruiting. It is a NA study. The enrollment target is 35 participants. The study started on 2025-07-23. Estimated completion is 2027-12.
What conditions does trial NCT06916741 study?
This clinical trial studies the following conditions: Femoral Artery, Cannulation.
What interventions are being tested in trial NCT06916741?
The interventions under investigation include: Ultrasound with Sacral lift (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06916741?
This trial is sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute), which has 34 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06916741 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.